Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Sorry, but I just had to laugh at 2 things today

If as Leckrone stated, the value (assume remaining value) of the MMP is only $1Billion and PTSC as we currently know doesn't produce anything, why would buy backs be a viable option? Why would anyone invest in a company that produces nothing and also has a limited shelf life for its patents. Dividends are the only means of bringing value to shareholders....of course IMHO.

Share
New Message
Please login to post a reply